Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Non-Current Assets: 2019-2024

Historic Non-Current Assets for Legend Biotech (LEGN) over the last 6 years, with Dec 2024 value amounting to $386.2 million.

  • Legend Biotech's Non-Current Assets rose 22.07% to $470.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $470.9 million, marking a year-over-year increase of 22.07%. This contributed to the annual value of $386.2 million for FY2024, which is 10.10% up from last year.
  • As of FY2024, Legend Biotech's Non-Current Assets stood at $386.2 million, which was up 10.10% from $350.8 million recorded in FY2023.
  • Legend Biotech's 5-year Non-Current Assets high stood at $386.2 million for FY2024, and its period low was $128.1 million during FY2020.
  • In the last 3 years, Legend Biotech's Non-Current Assets had a median value of $350.8 million in 2023 and averaged $323.0 million.
  • Data for Legend Biotech's Non-Current Assets shows a peak YoY surged of 58.97% (in 2020) over the last 5 years.
  • Legend Biotech's Non-Current Assets (Yearly) stood at $128.1 million in 2020, then skyrocketed by 32.36% to $169.6 million in 2021, then spiked by 36.69% to $231.8 million in 2022, then skyrocketed by 51.31% to $350.8 million in 2023, then rose by 10.10% to $386.2 million in 2024.